Lupus (SLE) Versus Arthritis. https://versusarthritis.org/about-arthritis/conditions/lupus-sle/.
Brent, L. H., MD. Lupus nephritis: Practice Essentials, pathophysiology, etiology. https://emedicine.medscape.com/article/330369-overview#:~:text=Lupus%20nephritis%20is%20clinically%20evident,clinical%20manifestations%20of%20kidney%20disease.
Musa, R., Brent, L. H. & Qurie, A. Lupus nephritis. StatPearls - NCBI Bookshelf https://www.ncbi.nlm.nih.gov/books/NBK499817/ (2023).
Pan, L. et al. Childhood-onset systemic lupus erythematosus: characteristics and the prospect of glucocorticoid pulse therapy. Frontiers in Immunology 14, (2023).
Lupus nephritis National Kidney Foundation. https://www.kidney.org/kidney-topics/lupus-nephritis#:~:text=Up%20to%203%20out%20of,within%2015%20years%20of%20diagnosis.
Lupus erythematosus is called the "immortal cancer" and can affect the whole body! Be careful if these symptoms appear - iNEWS (inf.news)
De Larrinoa, Í. R.-F. F. et al. Preventing organ damage in systemic lupus erythematosus: the impact of early biological treatment. Expert Opinion on Biological Therapy 22, 821–829 (2022).
Ms, C. M. B. M. Systemic Lupus erythematosus (SLE) medication: antimalarials, NSAIDs, DMARDS, immunomodulators, rheumatologics, other, corticosteroids, DMARDs, other, interferon antagonists, calcineurin inhibitors, calcineurin inhibitors. https://emedicine.medscape.com/article/332244-medication#showall.
Fanouriakis, A. et al. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Annals of the Rheumatic Diseases 83, 15–29 (2023).
